Presentation is loading. Please wait.

Presentation is loading. Please wait.

Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011.

Published byGrant Young Modified over 5 years ago

Similar presentations

Presentation on theme: "Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011."— Presentation transcript:

1 Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per population, EU/EEA, 2010–2014 Country 2010 2011 2012 2013 2014 Cases Rate National data Report type Reported cases Confirmed cases ASR Austria 85 1.0 49 0.6 56 0.7 Y C 37 35 0.4 Belgium 96 0.9 111 123 1.1 134 1.2 87 0.8 Bulgaria 8 0.1 13 0.2 12 A 15 Croatia . 41 26 33 Cyprus 1 6 2 4 0.5 Czech Republic 60 63 59 42 Denmark 66 72 1.3 55 45 Estonia 7 3 Finland 34 20 21 France 511 563 550 575 426 420 Germany 386 369 354 345 275 273 0.3 Greece 52 Hungary 67 51 47 Iceland Ireland 98 2.2 89 1.9 77 1.7 78 76 Italy 150 152 135 162 156 Latvia 5 9 Liechtenstein Lithuania 48 1.5 1.4 53 1.8 2.6 71 Luxembourg Malta 2.8 19 3.1 Netherlands 143 106 110 108 83 Norway 39 24 27 18 Poland 228 282 238 250 188 187 Portugal 79 69 61 Romania 68 70 Slovakia 31 29 23 Slovenia 11 Spain 404 431 335 262 198 146 Sweden 103 74 United Kingdom 1008 1.6 1036 862 852 758 750 EU/EEA 3713 3835 3513 3448 2873 2760 Source: Country reports. Legend: Y = yes, N = no, C = case based, · = no report, ASR: age-standardised rate Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

2 Figure 1. Reported, confirmed cases of invasive meningococcal disease, EU/EEA, 2014
Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

3 Figure 2. Number of cases of reported, confirmed invasive meningococcal disease per population, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

4 Figure 3. Cases of reported, confirmed invasive meningococcal disease, by age and gender, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Bulgaria, Croatia, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

5 Figure 4. Seasonal distribution of cases of reported, confirmed invasive meningococcal disease, EU/EEA, 2014 compared with 2010−2013 Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

6 Figure 5. Trend and number of cases of reported, confirmed invasive meningococcal disease, EU/EEA, 2010−2014 Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

7 Figure 6. Trend of confirmed cases of invasive meningococcal disease by serogroup, EU/EEA, 2010−2014
Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

8 Figure 7. Serogroup distribution of confirmed cases of invasive meningococcal disease by age group, EU/EEA, 2014 Source: Country reports from Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, the United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

9 Figure 8. Trend and number of cases of reported, confirmed invasive meningococcal disease, EU/EEA, 2010−2014 Contributing countries without MCC vaccination policy: Czech Republic, Denmark, Estonia, Finland, Hungary, Latvia, Lithuania, Malta, Norway, Poland, Romania, Slovakia, Slovenia, Sweden. Contributing countries with MCC vaccination policy: Austria, Belgium, Cyprus, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, the Netherlands, Portugal, Spain, United Kingdom. Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

10 Table. Invasive meningococcal disease, surveillance systems overview, 2014
Surveillance Data reported by Case definition used characteristics Country Data source L P H O Austria AT-Epidemiegesetz Cp Co C Y EU-2008 Belgium BE-REFLAB V Se A N Not specified/unknown Bulgaria BG-NATIONAL_SURVEILLANCE Croatia HR-CNIPH EU-2012 Cyprus CY-NOTIFIED_DISEASES Czech Republic CZ-MENI-NRL Denmark DK-LAB Estonia EE-NAKIS Finland FI-NIDR Other France FR-MANDATORY_INFECTIOUS_DISEASES Germany Greece EL-NOTIFIABLE_DISEASES Hungary HU-EFRIR Iceland IS-SUBJECT_TO_REGISTRATION Ireland IE-CIDR Italy IT-MENINGITIS Latvia LV-BSN Lithuania LT-COMMUNICABLE_DISEASES Luxembourg LU-SYSTEM1 EU-2002 Malta MT-DISEASE_SURVEILLANCE Netherlands NL-NRBM Norway NO-MSIS_A Poland PL-NATIONAL_SURVEILLANCE Portugal PT-MENINGOCOCAL Romania RO-RNSSy Slovakia SK-EPIS Slovenia SI-SURVIVAL Spain ES-STATUTORY_DISEASES Sweden SE-SMINET United Kingdom UK-MENINGOCOCCAL Surveillance characteristics: compulsory (Cp), comprehensive (co), voluntary (V), other (O), active (A), passive (P), case-based (C), aggregated (A) Data reported by: laboratories (L), physicians (P), hospitals (H), other (O) Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report Invasive meningococcal disease. Stockholm: ECDC; 2016. © European Centre for Disease Prevention and Control, Reproduction is authorised, provided the source is acknowledged

Download ppt "Table 1. Cases of reported, confirmed cases of invasive meningococcal disease: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011."

Similar presentations

1 Survey Data in ECA : Frequency, Coverage, Consistency and Access By Victor Sulla ECS-PE.

1 Survey Data in ECA : Frequency, Coverage, Consistency and Access By Victor Sulla ECS-PE.
European Union The Gay Perspective SCOREBOARD V 2.0.

European Union The Gay Perspective SCOREBOARD V 2.0.
Directive 95/50/EC TDG Checks Application of Annexes Erkki Laakso EUROPEAN COMMISSION DG ENERGY & TRANSPORT TDG Checks Riga 19-20 June 2006.

Directive 95/50/EC TDG Checks Application of Annexes Erkki Laakso EUROPEAN COMMISSION DG ENERGY & TRANSPORT TDG Checks Riga June 2006.
Erasmus+ International Credit Mobility Call for Proposals 2016

Erasmus+ International Credit Mobility Call for Proposals 2016
Table 1. Numbers and rates of TB cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:

Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,

Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per 100 000 population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.

Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.

CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.
Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.

Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Progress of European integration

Progress of European integration
  Surveillance Data reported by Case definition used characteristics

  Surveillance Data reported by Case definition used characteristics
Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.

Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014

Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014
Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.

Figure 1. Weekly proportion of sentinel specimens positive for influenza virus and number of detections by type and subtype, EU/EEA, 2014–2015 Suggested.
Table 1. Reported confirmed hepatitis A cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =

Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
DISTRIBUTION AUTOMATIC - GENERATION

DISTRIBUTION AUTOMATIC - GENERATION
Country 2010 2011 2012 2013 2014 Cases Rate National data Report type

Country Cases Rate National data Report type
Table 1. Reported invasive Haemophilus influenzae cases: number and rate per 100 000 population, EU/EEA, 2010–2014 Country 2010 2011 2012 2013 2014 Con­firmed.

Table 1. Reported invasive Haemophilus influenzae cases: number and rate per population, EU/EEA, 2010–2014 Country Con­firmed.
Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014

Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014

Similar presentations

Ads by Google